Elan rallies as Irish drugmaker plans review
January 13, 2009 at 04:51 AM EST
Shares of Elan rally as much as 17% in Dublin as the Irish drugmaker puts itself on the block following the troubles surrounding key multiple sclerosis and Alzheimerâs drugs.